AlgiPharma appoints Fredrik Alpsten as new Chief Financial Officer (CFO)
Mr Alpsten has an MSc degree from Stockholm School of Economics. He has 25 years of operational, financial, and strategic business experience as an executive in the life science field. He has served as Senior Vice President and CFO of Boule Diagnostics AB, a Swedish publicly-traded diagnostics company. During his time at Boule, he also served as President and CEO of Clinical Diagnostic Solutions Inc., a US subsidiary of Boule. He has also been CFO and Deputy CEO of IRRAS AB, a Swedish listed med-tech company and President and CEO of Doxa AB, a Swedish publicly-traded medical technology company. He currently serves as Chairman of the Board of Personlig Almanacka Nordic AB. He is also a board member and chairman of the audit committee of Binero Group AB (listed at Nasdaq) and board member of Pharmetheus AB.